Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Plaque Psoriasis”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Post-approval studies (Phase 4)Study completedNCT02340169
What this trial is testing

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 129
Large-scale testing (Phase 3)Study completedNCT01090427
What this trial is testing

The Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 110
Large-scale testing (Phase 3)Study completedNCT00078819
What this trial is testing

Etanercept (Enbrel®) in Psoriasis - Pediatrics

Who this might be right for
Psoriasis
Amgen 211
Large-scale testing (Phase 3)Active Not RecruitingNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Large-scale testing (Phase 3)Study completedNCT01251614
What this trial is testing

A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 114
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Post-approval studies (Phase 4)Study completedNCT02186665
What this trial is testing

Plaque Psoriasis Study in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Galderma R&D 19
Post-approval studies (Phase 4)Study completedNCT03988439
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 16
Not applicableStudy completedNCT05803187
What this trial is testing

Clinical Study of Stage IV Psoriasis in Children With Geleli

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 80
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Large-scale testing (Phase 3)Study completedNCT04175613
What this trial is testing

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 160
Large-scale testing (Phase 3)Active Not RecruitingNCT05172726
What this trial is testing

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Organon and Co 58
Post-approval studies (Phase 4)Study completedNCT01766440
What this trial is testing

PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 18
Post-approval studies (Phase 4)Study completedNCT02125279
What this trial is testing

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Galderma R&D 54
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Large-scale testing (Phase 3)Looking for participantsNCT06425549
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 168
Load More Results